The author discusses HTST pasteurization and UHT sterilization.
Pharmaceutical companies have stepped up gene therapy development in the wake of the approval of Glybera in 2012.
The US Supreme Court's Myriad decision satisfied both patient groups and patent holders
A science- and risk-based approach to verify and demonstrate that a process operating within predefined specified parameters consistently produces material that meets all its critical quality attributes.
An integrated focus on product design, development, operation, and control.
Ontario-area scientists discuss approaches to development of stem-cell therapies.